Article
A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Nov 2008
Molina-Vila Miguel A, Bertran-Alamillo Jordi, Reguart Noemí, Taron Miquel, Castellà Eva, Llatjós Mariona, Costa Carlota, Mayo Clara, Pradas Anna, Queralt Cristina, Botia Mónica, Pérez-Cano María, Carrasco Esther, Tomàs Mireia, Mate Jose Luis, Moran Teresa, Rosell Rafael
Abstract excerpt
BACKGROUND: Detection of epidermal growth factor receptor (EGFR) mutations in advanced non-small cell lung cancer (NSCLC) patients has relied on DNA purification from biopsies, amplification, and sequencing. However, the number of tumor cells in a sample is often insufficient for EGFR assessment. METHODS: We prospectively screened 1380 NSCLC patients for EGFR mutations but found that 268 were not evaluable...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
